Pharmaceuticals (lots, base price $1,200) is finished drug formulations supplied by healthcare and consumed by retail and clinical demand.
Market behaviour
Prices blend 50% global + 25% national (country-aggregate) + 25% regional (state), drifting toward equilibrium at 6% per turn (95% closed in one game year). Raw D/S remains visible for diagnosis; price and margin math use the same raw ratio up to 3x, then a softened effective pressure tail beyond that.
Sector profit margins are computed separately at three tiers — global, national, and local (state) — then blended at 50/25/25 by default. Tariff pressure shifts weight from the global leg to the national leg (local stays fixed at 25%), so a heavily-tariffed country becomes more sensitive to its own domestic supply chain. See Commodities for the full pricing mechanics and margin formula.
Who supplies it
Pharmaceuticals has no direct producing sector — supply is driven by the base market stabilizer and any seeded inventory.
Who demands it
Sectors that consume Pharmaceuticals as an input, with per-revenue demand rates:
- Healthcare — 11% of sector revenue
- Retail — 3% of sector revenue
Live distribution
Per-country totals below are pulled live from the current turn's market snapshot. Countries with positive net are exporters on balance; negative nets are importers.